Pfizer/BioNTech's COVID-19 Shot Receives Emergency Use Nod In Australia For Kids Aged 5-11 YearsBenzinga • 12/06/21
Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years. Is the Stock a Buy?The Motley Fool • 12/03/21
Europe To Start Deliveries Of Pfizer/BioNTech COVID-19 Shot For Children One Week Ahead Of Plan: ReutersBenzinga • 12/02/21
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine DosesBenzinga • 12/02/21
3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron VariantThe Motley Fool • 12/02/21
Pfizer Inc's (PFE) Management Presents at 4th Annual Evercore ISI HealthCONx Virtual Conference (Transcript)Seeking Alpha • 12/02/21